Cylera & Cisco Increase Healthcare IoT and Medical Device Security

Cylera and Cisco Increase Healthcare IoT and Medical Device Security 

Automated, Integrated, Device Data Sharing  

 

Cylera, a pioneer in healthcare IoT and medical device cybersecurity and intelligence, announces its deep integration with Cisco’s Network Access Control (NAC) product, the Cisco Identity Services Engine (ISE).  

 

Industry NAC solutions ensure that only authorised users and devices are granted access to network resources. However, especially in healthcare and clinical settings, NAC solutions alone are not able to identify the wide range of IoT and medical device (IoMT) types, device manufacturers, unique and specialised protocols, software, firmware, etc., nor able to establish the appropriate security policies for user and device access control for these devices. This leaves a gap in cybersecurity and policy which can be devastating to patient care and healthcare services. The Cylera and Cisco integration addresses this issue.  

 

Cylera MedCommand™ shares its unique and patented device discovery, asset profiles, vulnerabilities, risk details, and threat intelligence for all IoT and IoMT devices in the network – something that IT tools can’t typically provide.  

 

“Through our deployment experience, we know that many healthcare organisations are more or less operating blind when it comes to IoT and IoMT devices on their networks,” said Ryan Gonzales, Cylera’s VP of Solutions & Security Services. “The IT teams do not have next-generation tools in their hands to help them know IoT and medical device protocols, workflows, and what’s at risk if something should go awry. Also, Cylera has built and maintains its Cisco integrations in the standard MedCommand platform at no cost to our customers, and no consulting hours are required. Setup takes just a few seconds to configure and begin flowing device profiles and policies from Cylera to Cisco’s ISE.” 

  

Through Cylera’s integration with Cisco, joint customers can now: 

Experience a whole new level of insight on their connected IoT and IoMT devices, performed agentlessly and passively, with zero device impact during vulnerability and risk analysis, and absolutely no disruption to patient care, privacy, or safety. 

 

Share data on new IoT and IoMT devices found by Cylera, to keep the ISE dashboard informed of assets with needed, granular details and updates over time on the devices in the network.  

 

Know the location of medical devices and IoT in the enterprise, what specifically the devices are, all the needed hardware, software, and firmware level information, and many other asset attributes.  

 

Save IT security teams endless hours in manual creation and maintenance of inventory/register of connected IoT and medical devices which can be shared automatically with Cisco ISE.  

 

Based on accurate knowledge of IoT and IoMT devices and their communication patterns and clinical context, Cisco TrustSec or dACL/SGACL policies can be created automatically and shared to Cisco ISE. This helps ISE administrators save time and eliminate human error. (A dACL is a “downloadable Access Control List” and a SGACL is a “Security Group Access Control List.”)  

  

Solve micro-segmentation limitations by automatically creating and adjusting the Security Group Tags (SGTs) for IoT and IoMT devices that attach to the network. This means that enforcement of segmentation rules can be enacted by Cisco TrustSec technology which is embedded into the network fabric on all modern Cisco switches. 

 

Leverage and extend the value of customers’ existing IT infrastructure investments – saving cost, time, and resources. 

 

“In the past few years, both during Covid and now post-Covid, we’ve seen attacks and intrusions targeted at healthcare networks like never before,” said Timur Ozekcin, Cylera’s CEO and co-founder. “Both IT security and clinical engineering groups need know their connected IoT and IoMT devices, and that they have protection in place to assure the right access is being granted for the right users to the right resources. It’s become a business essential.” 

 

Cylera is an IoT security partner with Cisco as well as a Cisco Technical Alliance Partner Ecosystem member. With its integration to Cisco Prime’s wired and wireless IT management, Cylera can combine location information with Cylera’s knowledge of the device details, to help modernise how quickly staff can find the assets they need for patient care, or when an issue comes up with devices. Integration with Cisco’s DNA Centre assures that asset device software updates, patching, license status and other underlying data are synchronised across Health Information Technology (HIT) and Health Technology Management (HTM) systems.  

   

The Cylera MedCommand platform delivers a full suite of capabilities: IoT, IoMT, IT and even some Operational Technology (OT) asset identification and management, network analysis, vulnerability and risk assessment, network segmentation, threat detection and intelligence, and fleet utilisation and optimisation. All of these capabilities are undergirded by Cylera’s next-generation, patented technology, and commitment to make healthcare delivery a safer, simpler, more secure environment. See www.cylera.com for more information, and download the Cylera – Cisco ISE Integration Brief. 

 

END   

 Please click here to visit the Cylera virtual news room, where you can find 

Headshot of Timur Ozekcin, Cylera’s CEO and co-founder 

Bio of Timur Ozekcin, Cylera’s CEO and co-founder 

 

https://www.linkedin.com/in/timur-ozekcin-6a0b7574/  

UK Press contact:    

Verity Blake/David Ferguson/Emily Goold at HeadOn PR   

cylera@headonpr.co.uk 

01242 335 246/07920792183    

   

About Cylera   

Cylera is pioneering agentless healthcare IoT and medical device (IoMT) cybersecurity and intelligence, with a mission to safeguard what matters most: patient care, safety, privacy, and business continuity. Cylera is a privately held company, headquartered in New York City with offices in Cheltenham, U.K. and Madrid, Spain. www.cylera.com 

 

 

 

 

Timur Ozeckin CEO of Cylera

Timur Ozekcin

Co-founder and Chief Executive Officer

https://www.cylera.com/

Timur Ozekcin is the Co-founder and Chief Executive Officer of Cylera, a leader in agentless cybersecurity and intelligence, with a mission to safeguard the devices that matter most to leading organizations across healthcare providers, enterprises, and government agencies. Cylera delivers a holistic, asset-centric cybersecurity platform that identifies all devices, analyses risks and vulnerabilities, and mitigates threats in real-time, helping organizations separate the signal from the noise.

Having experience in healthcare cybersecurity policy and biomedical engineering, Tim leads Cylera through the ever-changing healthcare industry to deliver world class technologies to its global healthcare clients. Prior to Cylera, he was the Co-founder of a medical device and technology start-up Heuristics Health.

Additionally, he worked for a non-profit consortium funded by the Department of Homeland Security which focused on the safety and security of medical devices within healthcare organisations. He holds a Bachelor of Science in Biological Engineering, a Master’s in Mechanical Engineering from Cornell University, and a Master’s in Public Health focusing on Healthcare Policy from Columbia University. Tim is widely recognized for his contributions in the cyber space industry and has been named in The Top 50 Healthcare Technology CEOs of 2022.   

https://www.linkedin.com/in/timur-ozekcin-6a0b7574/

Data-Sharing Done Right: Finding the Best Business Approach

Bart Koek • 20th November 2024

To ensure data is not only available, but also accessible to those that need it, businesses recognise that it is vital to focus on collecting, sorting and governing all the data in their organisation. But what happens when data also needs to be accessed and shared across the business? That is where organisations discover a...

Nova: The Ultimate AI-Powered Martech Solution for Boosting Sales, Marketing...

Erin Lanahan • 19th November 2024

Discover how Nova, the AI-powered engine behind Launched, revolutionises Martech by automating sales and marketing tasks, enhancing personalisation, and delivering unmatched ROI. With advanced intent data integration, revenue attribution, and real-time insights, Nova empowers businesses to scale, streamline operations, and outperform competitors like 6Sense and 11x.ai. Experience the future of Martech with Nova’s transformative AI...

How E-commerce Marketers Can Win Black Friday

Sue Azari • 11th November 2024

As new global eCommerce players expand their influence across both European and US markets, traditional brands are navigating a rapidly shifting landscape. These fast-growing Asian platforms have gained traction by offering ultra-low prices, rapid product turnarounds, heavy investment in paid user acquisition, and leveraging viral social media trends to create demand almost in real-time. This...

Why microgrids are big news

Craig Tropea • 31st October 2024

As the world continues its march towards a greener future, businesses, communities, and individuals alike are all increasingly turning towards renewable energy sources to power their operations. What is most interesting, though, is how many of them are taking the pro-active position of researching, selecting, and implementing their preferred solutions without the assistance of traditional...

Is automation the silver bullet for customer retention?

Carter Busse • 22nd October 2024

CX innovation has accelerated rapidly since 2020, as business and consumer expectations evolved dramatically during the Covid-19 pandemic. Now, finding the best way to engage and respond to customers has become a top business priority and a key business challenge. Not only do customers expect the highest standard, but companies are prioritising superb CX to...

Automated Testing Tools and Their Impact on Software Quality

Natalia Yanchii • 09th October 2024

Test automation refers to using specialized software tools and frameworks to automate the execution of test cases, thereby reducing the time and effort required for manual testing. This approach ensures that automation tests run quickly and consistently, allowing development teams to identify and resolve defects more effectively. Test automation provides greater accuracy by eliminating human...